254 related articles for article (PubMed ID: 11162827)
1. Antibody neutralization of the extracellular enveloped form of vaccinia virus.
Law M; Smith GL
Virology; 2001 Feb; 280(1):132-42. PubMed ID: 11162827
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
[TBL] [Abstract][Full Text] [Related]
4. Extracellular enveloped vaccinia virus escapes neutralization.
Ichihashi Y
Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
[TBL] [Abstract][Full Text] [Related]
5. Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.
Aldaz-Carroll L; Whitbeck JC; Ponce de Leon M; Lou H; Hirao L; Isaacs SN; Moss B; Eisenberg RJ; Cohen GH
J Virol; 2005 May; 79(10):6260-71. PubMed ID: 15858010
[TBL] [Abstract][Full Text] [Related]
6. Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread.
Law M; Hollinshead R; Smith GL
J Gen Virol; 2002 Jan; 83(Pt 1):209-222. PubMed ID: 11752718
[TBL] [Abstract][Full Text] [Related]
7. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope.
Vanderplasschen A; Mathew E; Hollinshead M; Sim RB; Smith GL
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7544-9. PubMed ID: 9636186
[TBL] [Abstract][Full Text] [Related]
8. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
Engelstad M; Smith GL
Virology; 1993 Jun; 194(2):627-37. PubMed ID: 8503178
[TBL] [Abstract][Full Text] [Related]
9. Studying the binding and entry of the intracellular and extracellular enveloped forms of vaccinia virus.
Law M; Smith GL
Methods Mol Biol; 2004; 269():187-204. PubMed ID: 15114017
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation.
Vanderplasschen A; Hollinshead M; Smith GL
J Gen Virol; 1997 Aug; 78 ( Pt 8)():2041-8. PubMed ID: 9267005
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
[TBL] [Abstract][Full Text] [Related]
12. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation.
Mathew E; Sanderson CM; Hollinshead M; Smith GL
J Virol; 1998 Mar; 72(3):2429-38. PubMed ID: 9499104
[TBL] [Abstract][Full Text] [Related]
13. Extracellular enveloped vaccinia virus. Entry, egress, and evasion.
Smith GL; Vanderplasschen A
Adv Exp Med Biol; 1998; 440():395-414. PubMed ID: 9782308
[TBL] [Abstract][Full Text] [Related]
14. The effects of targeting the vaccinia virus B5R protein to the endoplasmic reticulum on virus morphogenesis and dissemination.
Mathew EC; Sanderson CM; Hollinshead R; Hollinshead M; Grimley R; Smith GL
Virology; 1999 Dec; 265(1):131-46. PubMed ID: 10603324
[TBL] [Abstract][Full Text] [Related]
15. Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon.
Lorenzo MM; Galindo I; Griffiths G; Blasco R
J Virol; 2000 Nov; 74(22):10535-50. PubMed ID: 11044098
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain.
Herrera E; Lorenzo MM; Blasco R; Isaacs SN
J Virol; 1998 Jan; 72(1):294-302. PubMed ID: 9420227
[TBL] [Abstract][Full Text] [Related]
17. Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface.
Rodger G; Smith GL
J Gen Virol; 2002 Feb; 83(Pt 2):323-332. PubMed ID: 11807225
[TBL] [Abstract][Full Text] [Related]
18. Intracellular and extracellular vaccinia virions enter cells by different mechanisms.
Vanderplasschen A; Hollinshead M; Smith GL
J Gen Virol; 1998 Apr; 79 ( Pt 4)():877-87. PubMed ID: 9568984
[TBL] [Abstract][Full Text] [Related]
19. Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement.
Lustig S; Fogg C; Whitbeck JC; Moss B
Virology; 2004 Oct; 328(1):30-5. PubMed ID: 15380355
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of B5R mutants of rabbitpox virus in vivo is related to impaired growth and not an enhanced host inflammatory response.
Stern RJ; Thompson JP; Moyer RW
Virology; 1997 Jun; 233(1):118-29. PubMed ID: 9201221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
